StockWatch
·
Pharmaceuticals
Quarterly Result12 Feb 2026, 04:53 pm

Syncom Formulations India Ltd. Submits Unaudited Financials for Q3 and Nine Months of FY2025-26

AI Summary

Syncom Formulations India Ltd. has submitted its unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December, 2025. The results were approved in a Board meeting on 12th February, 2026. The company will file the results in XBRL format and publish them in English and Marathi newspapers.

Key Highlights

  • Unaudited standalone and consolidated financial results for Q3 and nine months of FY2025-26 submitted
  • Results approved in a Board meeting on 12th February, 2026
  • Company to file results in XBRL format
  • Results to be published in English and Marathi newspapers